← Back to headlines
Nautilus Biotechnology Reports Q1 GAAP EPS of -$0.12, Beats Estimates
Nautilus Biotechnology announced its GAAP EPS for the quarter was -$0.12, surpassing analyst estimates by $0.02. The company's earnings report provides an update on its financial performance.
28 Apr, 12:05 — 28 Apr, 12:05
Sources
Showing 1 of 1 sources
